Investigative Ophthalmology & Visual Science 2010-03-01

cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.

Owen Jeffries, Mary K McGahon, Peter Bankhead, Maria Manfredi Lozano, C Norman Scholfield, Tim M Curtis, J Graham McGeown

Index: Invest. Ophthalmol. Vis. Sci. 51(3) , 1591-8, (2010)

Full Text: HTML

Abstract

To investigate the effects of arginine vasopressin (AVP) on Ca(2+) sparks and oscillations and on sarcoplasmic reticulum (SR) Ca(2+) content in retinal arteriolar myocytes.Fluo-4-loaded smooth muscle in intact segments of freshly isolated porcine retinal arteriole was imaged by confocal laser microscopy. SR Ca(2+) store content was assessed by recording caffeine-induced Ca(2+) transients with microfluorimetry and fura-2.The frequencies of Ca(2+) sparks and oscillations were increased both during exposure to, and 10 minutes after washout of AVP (10 nM). Caffeine transients were increased in amplitude 10 and 90 minutes after a 3-minute application of AVP. Both AVP-induced Ca(2+) transients and the enhancement of caffeine responses after AVP washout were inhibited by SR 49059, a V(1a) receptor blocker. Forskolin, an activator of adenylyl cyclase, also persistently enhanced caffeine transients. Rp-8-HA-cAMPS, a membrane-permeant PKA inhibitor, prevented enhancement of caffeine transients by both AVP and forskolin. Forskolin, but not AVP, produced a reversible, Rp-8-HA-cAMPS insensitive reduction in basal [Ca(2+)](i).AVP activates a cAMP/PKA-dependent pathway via V(1a) receptors in retinal arteriolar smooth muscle. This effect persistently increases SR Ca(2+) loading, upregulating Ca(2+) sparks and oscillations, and may favor prolonged agonist activity despite receptor desensitization.


Related Compounds

Related Articles:

The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.

2015-06-01

[Neuropeptides 51 , 63-73, (2015)]

Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

2015-05-01

[Diabetologia 58(5) , 1081-90, (2015)]

Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model.

2012-11-01

[Am. J. Respir. Cell. Mol. Biol. 47(5) , 583-8, (2012)]

Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor.

2006-05-26

[J. Biol. Chem. 281(21) , 14604-14, (2006)]

Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.

2011-03-01

[Neurochem. Int. 58(4) , 542-8, (2011)]

More Articles...